117 results match your criteria: "Paris-Est Créteil University (UPEC)[Affiliation]"

Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.

World J Pediatr

January 2025

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France.

Background: Data on biosimilar use in pediatric inflammatory bowel diseases (IBD) are scarce compared to the status of studies in adults, resulting in limitations in its treatment. We compared effectiveness and safety of biosimilars versus originators in this population.

Methods: We used data from the French National Health Data System to identify children (less than 18 years old at treatment initiation) initiating treatment with a biosimilar or the originator infliximab or adalimumab for Crohn's disease (CD) or ulcerative colitis (UC), from first biosimilar launch (January 2015 and October 2018, respectively) to 31 December 2022.

View Article and Find Full Text PDF

The TOPASE study was set up to evaluate the outcomes of chronic myeloid leukaemia [CML] patients treated with ponatinib (PON) in a real-world setting in France. One hundred and twenty CML patients, 105 in chronic phase (CP), 8 in accelerated phase (AP) and 7 in blastic phase (BP) were included. Fifty-one (49%) of the CP-CML patients were in third line of treatment.

View Article and Find Full Text PDF

Prolonged use of chlormadinone acetate and risk of intracranial meningioma: A population-based cohort study.

Eur J Neurol

January 2025

EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France.

Background And Purpose: Chlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure.

Method: An observational cohort study was conducted based on the French national health data system. Women aged 10-70 years and who started CMA between 2007 and 2017 were included.

View Article and Find Full Text PDF

Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.

J Am Soc Nephrol

October 2024

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.

Article Synopsis
  • A retrospective study of 183 adult patients treated with rituximab for podocytopathies showed that 82% achieved complete or partial remission within 6 months.
  • *Long-term follow-up revealed that 55% of initial responders maintained relapse-free survival over three years, with improved outcomes linked to maintenance therapy.
  • *Patients on maintenance therapy experienced significantly fewer relapses per year and maintained stable kidney function compared to non-responders.
View Article and Find Full Text PDF

Mitochondria at the crossroad of dysregulated inflammatory and metabolic processes in bipolar disorders.

Brain Behav Immun

January 2025

INSERM U955 IMRB, Translational Neuropsychiatry laboratory, AP-HP, Hôpital Henri Mondor, DMU IMPACT, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Paris Est Créteil University (UPEC), Fondation FondaMental, ECNP Immuno-NeuroPsychiatry Network, 94010 Créteil, France. Electronic address:

In last few decades, considerable evidence has emphasized the significant involvement of mitochondria, often referred to as the "powerhouse of the cell," in the pathophysiology of bipolar disorder (BD). Given crucial mitochondrial functions in cellular metabolism and inflammation, both of which are compromised in BD, this perspective review examines the central role of mitochondria in inflammation and metabolism within the context of this disorder. We first describe the significance of mitochondria in metabolism before presenting the dysregulated inflammatory and metabolic processes.

View Article and Find Full Text PDF

Deep learning enabled label-free microfluidic droplet classification for single cell functional assays.

Front Bioeng Biotechnol

September 2024

Institut Pasteur, Université Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM), Unité Mixte de Recherche (UMR) 1222, Antibodies in Therapy and Pathology, Paris, France.

Droplet-based microfluidics techniques coupled to microscopy allow for the characterization of cells at the single-cell scale. However, such techniques generate substantial amounts of data and microscopy images that must be analyzed. Droplets on these images usually need to be classified depending on the number of cells they contain.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates why recruitment rates in inflammatory bowel disease (IBD) trials are declining, focusing on screen failure (SF) proportions and their causes across phase 2 and 3 trials for ulcerative colitis (UC) and Crohn's disease (CD).
  • - An analysis of 17 clinical trials revealed that 43% of UC patients and 53% of CD patients experienced SF, with key reasons being inability to meet specific clinical and endoscopic criteria, along with infections like Clostridium difficile.
  • - The findings highlight that high SF rates, especially in CD trials, hinder patient recruitment, largely due to rigid and often unclear eligibility criteria.
View Article and Find Full Text PDF

Immuno-psychiatry: Dreams or reality?

Eur Neuropsychopharmacol

December 2024

Paris Est Créteil University (UPEC), AP-HP, University Hospital Henri Mondor (Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), INSERM U955 IMRB, Translational Neuropsychiatry laboratory, Fondation FondaMental ECNP Immuno-NeuroPsychiatry Network, France. Electronic address:

View Article and Find Full Text PDF

Diet quality and associations with lactate and metabolic syndrome in bipolar disorder.

J Affect Disord

November 2024

Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Mitochondrial Innovation Initiative, MITO2i, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

Background: Nutrition is largely affected in bipolar disorder (BD), however, there is a lack of understanding on the relationship between dietary categories, BD, and the prevalence of metabolic syndrome. The objective of this study is to examine dietary trends in BD and it is hypothesized that diets with increased consumption of seafood and high-fiber carbohydrates will be correlated to improved patient outcomes, and a lower frequency of metabolic syndrome.

Methods: This retrospective cohort study includes two French cohorts.

View Article and Find Full Text PDF

Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.

Psychiatry Res

September 2024

Department of Pharmacology and Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Mitochondrial Innovation Initiative, MITO2i, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Article Synopsis
  • This study investigates the link between mitochondrial blood biomarkers, specifically lactate and circulating cell-free mitochondrial DNA, and markers of metabolic syndrome in bipolar disorder patients, hypothesizing that lactate levels would be higher in those with metabolic syndrome.
  • The research involved a large cohort of 837 stable bipolar disorder patients and 237 others for validation, revealing that higher lactate levels correlated significantly with factors like triglycerides and blood pressure, indicating a strong association with metabolic syndrome.
  • The findings suggest that while lactate is a key biomarker related to metabolic syndrome in bipolar patients, circulating mitochondrial DNA levels do not show this same correlation, highlighting the potential for personalized treatment strategies based on these metabolite profiles.
View Article and Find Full Text PDF

Agreement between two real-time commercial PCR kits and an in-house real-time PCR for diagnosis of mucormycosis.

Microbiol Spectr

August 2024

Université Paris Cité, Faculté de Médecine, APHP, Hôpital Necker Enfants-Malades, Hôpital Européen Georges Pompidou, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France.

Unlabelled: Mucormycosis is a severe and emerging invasive fungal infection associated with high mortality rates. Early diagnosis is crucial for initiating specific antifungal treatment, with molecular tools currently representing the most efficient diagnostic approach. Presently, a standardized in-house real-time PCR method is widely employed for diagnosing mucormycosis.

View Article and Find Full Text PDF
Article Synopsis
  • * Among 976 CA patients, the prevalence of AS was notably higher in those with wild type transthyretin amyloid (ATTRwt) at 26%, compared to 8% in hereditary variant transthyretin amyloid (ATTRv) and 5% in immunoglobulin light-chain (AL) CA.
  • * Despite ATTRwt patients having a higher prevalence of AS than hospital controls, moderate or greater AS did not significantly impact overall mortality risk in this group.
View Article and Find Full Text PDF

Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study.

Lancet Reg Health Eur

July 2024

EPI-PHARE Scientific Interest Group (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France.

Background: Nomegestrol acetate (NOMAC) is a synthetic potent progestogen. This study aimed to assess the risk of intracranial meningioma associated with the prolonged use of NOMAC.

Methods: Observational cohort study using SNDS data (France).

View Article and Find Full Text PDF

Invasive fungal infections have recently been recognized by the WHO as a major health, epidemiological, and economic issue. Their high mortality rates and the emergence of drug resistance have driven the development of new molecules, including olorofim, an antifungal belonging to a new family of compounds, the orotomides. A review was conducted on the PubMed database and the ClinicalTrials.

View Article and Find Full Text PDF

Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study.

Clin Gastroenterol Hepatol

December 2024

Department of Gastroenterology, INFINY Institute, FHU-CURE, INSERM NGERE, Nancy University Hospital, Vandœuvre-lès-Nancy, France.

Background & Aims: The aim of this study was to assess the long-term effectiveness and safety of risankizumab maintenance treatment in a large real-world cohort of patients with Crohn's Disease (CD).

Methods: From May 2021 to August 2023, all consecutive patients with CD treated with risankizumab in 25 GETAID centers have been retrospectively included. The primary endpoint was steroid-free clinical remission (Harvey Bradshaw Index [HBI] <5) at 52 weeks.

View Article and Find Full Text PDF

Vedolizumab (VDZ) is a first-line treatment in ulcerative colitis (UC) that targets the α4β7- mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1) axis. To determine the mechanisms of action of VDZ, we examined five distinct cohorts of patients with UC. A decrease in naïve B and T cells in the intestines and gut-homing (β7) plasmablasts in circulation of VDZ-treated patients suggested that VDZ targets gut-associated lymphoid tissue (GALT).

View Article and Find Full Text PDF

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective.

EClinicalMedicine

April 2024

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance Publique - Hôpitaux de Paris (AP-HP), Clinical Investigation Center (CIC-1901), Regional Pharmacovigilance Centre, Department of Pharmacology, Pitié-Salpêtrière Hospital, Paris, France.

Article Synopsis
  • Immune-checkpoint inhibitors (ICI) have transformed cancer treatment by utilizing the immune system, but they can cause serious, life-threatening immune-related adverse events (irAE) that can affect various organs.
  • Analysis of data from the international pharmacovigilance database revealed 25 types of irAE across over 50,000 cases, with skin reactions and pneumonitis being the most common, and a shift in treatment regimens favoring anti-PD1 and anti-PDL1 therapies after 2016.
  • Specific risk factors for certain irAE include cancer types and treatment regimens, with a median onset time for complications varying greatly; this underscores the importance of monitoring during ICI therapy
View Article and Find Full Text PDF

Use of progestogens and the risk of intracranial meningioma: national case-control study.

BMJ

March 2024

EPI-PHARE Scientific Interest Group, French National Agency for Medicines and Health Products Safety, French National Health Insurance, Saint-Denis, France.

Objective: To assess the risk of intracranial meningioma associated with the use of selected progestogens.

Design: National case-control study.

Setting: French National Health Data System (ie, ).

View Article and Find Full Text PDF

Late opportunistic infections (OI) occurring beyond the first year after kidney transplantation (KT) are poorly described and not targeted by prophylactic strategies. We performed a ten-year retrospective monocentric cohort study describing epidemiology, risk factors and impact of late OI occurring 1 year after KT. We included clinically symptomatic OI requiring treatment besides BK virus nephropathy.

View Article and Find Full Text PDF

Objective: To assess the effectiveness and safety of a rigorous short-term supine position in preventing inadvertent retinal displacement after pars plana vitrectomy (PPV) with gas tamponade for rhegmatogenous retinal detachment (RRD).

Methods: We conducted a retrospective observational analysis of a case series at two ophthalmological surgical centers. We included eyes diagnosed with macula-off RRD that maintained a strict face-up position for three hours immediately after PPV with intraoperative perfluorocarbon liquid (PFCL) and 20% sulfur hexafluoride (SF6) tamponade.

View Article and Find Full Text PDF

Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases: an observational study on the French National Health Data System.

RMD Open

March 2024

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), Saint-Denis, France.

Article Synopsis
  • The study aimed to compare the persistence and safety of biosimilar medications versus their originator counterparts for infliximab, etanercept, and adalimumab in various medical conditions.
  • Researchers utilized extensive data from the French National Health Data System, tracking nearly 87,000 patients from the launch of biosimilars in 2015, 2016, and 2018 until June 2021, with a follow-up period of one year.
  • Results indicated no significant difference in treatment discontinuation rates or safety events, suggesting biosimilars are as safe and effective as their originators across all licensed indications.
View Article and Find Full Text PDF

Association between Psychotic Disorders and Psoriasis or Psoriatic Arthritis: Cohort Study of French Health Insurance Database.

J Invest Dermatol

July 2024

Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, Paris Est Créteil University (UPEC), Créteil, France; Department of Dermatology, Hôpital Henri Mondor, Créteil, France.

View Article and Find Full Text PDF

Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.

J Invest Dermatol

March 2024

Dermatology Department, Henri Mondor Hospital, Assitance Publique Hôpitaux de Paris (AP-HP), Créteil, France; Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE), Paris Est Créteil University (UPEC), Créteil, France; University Hospital Federation (FHU) TRUE (InnovaTive theRapy for immUne disordErs), Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Créteil, France; INSERM, Clinical Investigation Centre 1430, Henri Mondor Hospital, Créteil, France.

View Article and Find Full Text PDF

How anesthesiology can deal with innovation and new technologies?

Minerva Anestesiol

February 2024

Department of Anesthesia and Intensive Care, Cochin University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Innovation and new technologies have always impacted significantly the anesthesiology practice all along the perioperative course, as it is recognized as one of the most transformative medical specialties specifically regarding patient's safety. Beside a number of major changes in procedures, equipment, training, and organization that aggregated to establish a strong safety culture with effective practices, anesthesiology is also a stakeholder in disruptive innovation. The present review is not exhaustive and aims to provide an overview on how innovation could change and improve anesthesiology practices through some examples as telemedicine (TM), machine learning and artificial intelligence (AI).

View Article and Find Full Text PDF

Acute severe ulcerative colitis (ASUC) occurs in up to 25% of patients with ulcerative colitis (UC). Therapeutic approaches have evolved during the past years with the increasing bio exposure of admitted patients and the extension of the number of approved drugs for UC. In this review, we aimed to summarize the latest evidence in short-term and long-term medical strategies for ASUC.

View Article and Find Full Text PDF